# ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

> **NCT04889924** · NA · RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 820 (estimated)

## Conditions studied

- Breast Cancer
- Chemotherapy
- Sentinel Lymph Node
- Axillary Lymph Nodes Dissection
- Radiotherapy Side Effect

## Interventions

- **RADIATION:** Axillary Radiotherapy
- **PROCEDURE:** Lymphadenectomy

## Key facts

- **NCT ID:** NCT04889924
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-11
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 820 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04889924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04889924, "ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04889924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*